ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,453Medicare Part D Prescriptions Filled, Including Refills

Rank: 525 out of 3593

$296K Total Retail Price of All Prescriptions

Rank: 1418 out of 3593

517 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,634 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 689 625 1 1
OMEPRAZOLE 530 445 2 5
LEVOTHYROXINE SODIUM 461 411 3 4
LISINOPRIL 421 336 4 2
HYDROCODONE-ACETAMINOPHEN 309 219 S3 5 7
FUROSEMIDE 260 241 6 9
METFORMIN HCL 243 228 7 6
METOPROLOL TARTRATE 233 210 8 8
HYDROCHLOROTHIAZIDE 205 179 9 10
ATENOLOL 204 186 10 11
ALPRAZOLAM 193 138 11 37
AMLODIPINE BESYLATE 183 158 12 3
GABAPENTIN 172 135 13 16
LOVASTATIN 169 158 14 20
TEMAZEPAM 164 158 15 56
RANITIDINE HCL 161 106 16 27
GLIPIZIDE 155 143 17 40
LOSARTAN POTASSIUM 150 146 18 14
WARFARIN SODIUM 140 97 19 18
POTASSIUM CHLORIDE 123 118 20 24
ZOLPIDEM TARTRATE 121 114 21 12
SERTRALINE HCL 117 97 22 28
ALLOPURINOL 113 110 23 35
DOXAZOSIN MESYLATE 108 97 24 63
IBUPROFEN 92 66 25 43
METHYLPREDNISOLONE 91 70 26 103
OXYBUTYNIN CHLORIDE 88 81 27 104
CRESTOR 87 80 28 21
TAMSULOSIN HCL 85 73 29 33
PREDNISONE 85 84 29 49
BENAZEPRIL HCL 80 78 31 69
VENTOLIN HFA 79 50 32 80
MELOXICAM 78 64 33 29
NOVOLIN N 78 74 33 340
TRAMADOL HCL 77 67 35 17
PROAIR HFA 76 55 36 54
CLONIDINE HCL 75 65 37 41
CIPROFLOXACIN HCL 75 52 37 52
DIAZEPAM 74 51 39 252
LEVOTHROID 74 66 39 375
DIGOXIN 71 60 41 58
BACLOFEN 68 44 42 109
GEMFIBROZIL 62 58 43 88
FLUTICASONE PROPIONATE 61 31 44 32
METOPROLOL SUCCINATE 61 61 44 19
FLUOXETINE HCL 60 56 46 60
VIAGRA 58 58 47 84
GLYBURIDE 57 56 R 48 55
AMITRIPTYLINE HCL 53 46 R 49 90
CITALOPRAM HBR 53 40 49 25
CLOPIDOGREL 52 49 51 30
DILTIAZEM ER 50 44 52 194
DONEPEZIL HCL 50 50 52 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.